New research suggests a link between obstructive sleep apnea (OSA) and subtle changes in the tiny blood vessels of the retina, the light-sensitive tissue at the back of the eye. The findings, published in the journal Ophthalmology, indicate that individuals with OSA may exhibit reduced blood flow in a specific layer of the retina, potentially offering a new avenue for early detection and monitoring of this common, yet often underdiagnosed, condition. This research focuses on obstructive sleep apnea syndrome and its impact on retinal microvasculature.
The study, known as the Retinal Vascular Network and Obstructive Sleep Apnea (ORNET) trial (NCT03979001), involved 162 adults – 82 diagnosed with OSA and 80 serving as a control group. Researchers used a non-invasive imaging technique called optical coherence tomography angiography (OCT-A) to visualize the retinal blood vessels. Participants underwent overnight sleep studies (polysomnography) to confirm the presence and severity of OSA, defined as an apnea-hypopnea index (AHI) greater than 5, coupled with reported daytime sleepiness.
While overall retinal blood vessel structure appeared similar between the two groups, a significant difference emerged in the deep capillary plexus (DCP) – the innermost layer of retinal blood vessels. Individuals with OSA showed a noticeable reduction in both vessel density and blood flow within this layer. This suggests that OSA may disrupt the microvascular network responsible for supplying oxygen and nutrients to the retina. The study ran from January 6, 2020, to December 13, 2023, providing a substantial timeframe for data collection, and analysis.
The Link Between Sleep Apnea and Retinal Microvascular Changes
Obstructive sleep apnea occurs when the muscles in the back of the throat relax during sleep, causing repeated pauses in breathing. These pauses lead to drops in blood oxygen levels and increased carbon dioxide, creating a cycle of stress on the cardiovascular system. It’s well-established that OSA is linked to conditions like hypertension, heart disease, and stroke. This new research suggests that the impact of OSA may extend to the delicate blood vessels of the eye.
“The retina is an extension of the brain, and its blood vessels share many characteristics with those found throughout the body,” explains Dr. Grace Chen, a board-certified physician and medical writer. “Changes in retinal blood flow can therefore serve as a window into the overall health of the vascular system. The DCP, in particular, is highly sensitive to changes in blood pressure and oxygen levels, making it a potential early indicator of OSA-related damage.”
Participants in the study with OSA had a higher prevalence of other health conditions known to be associated with the sleep disorder, including hypertension (35.4% vs. 13.8%), diabetes (12.2% vs. 2.5%), and vascular disease (13.4% vs. 2.5%). They were also more likely to be current smokers (21.9% vs. 15.0%).
CPAP Therapy and Retinal Blood Flow: A Complex Picture
The study also investigated whether continuous positive airway pressure (CPAP) therapy – the most common treatment for OSA – could reverse the observed retinal changes. CPAP delivers a constant stream of air through a mask, keeping the airway open during sleep. While patients who consistently used CPAP (defined as adherence at 3-6 months) showed some improvement in retinal blood flow, these benefits were not sustained over the longer term (18-24 months). CPAP compliance rates were 54.0% at 3-6 months and declined to 44.4% at 18-24 months, with those experiencing severe OSA demonstrating better adherence.
Researchers attribute this lack of long-term benefit to several factors, including inconsistent CPAP employ and the potential for underlying vascular damage to be irreversible. The study highlights the importance of adherence to CPAP therapy, but also suggests that other interventions may be needed to protect the retinal microvasculature in individuals with OSA.
Limitations and Future Directions
The researchers acknowledge several limitations to their study. Notably, the control group was screened for OSA risk using questionnaires (Berlin and STOP-BANG) but did not undergo polysomnography to definitively rule out the condition. This means there’s a possibility some individuals in the control group may have had mild, undiagnosed OSA. The study focused on a relatively little area of the retina using OCT-A, and the low adherence rates to CPAP therapy could have influenced the long-term treatment efficacy results.
Despite these limitations, the findings offer a promising step toward identifying a non-invasive biomarker for OSA. Further research is needed to validate these findings in larger, more diverse populations and to explore the potential of OCT-A as a tool for monitoring the effectiveness of OSA treatment. The research team emphasizes the require for cautious interpretation of longitudinal CPAP-related effects.
The study’s findings underscore the importance of addressing OSA not only for its well-known systemic effects but also for its potential impact on eye health. Early detection and effective management of OSA may help protect the delicate retinal blood vessels and preserve vision. Individuals concerned about OSA should consult with a healthcare professional for diagnosis and treatment options.
Disclaimer: This article provides general information and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
The next step in this research will be to investigate whether early intervention with CPAP therapy can prevent the development of retinal microvascular changes in individuals at high risk for OSA. Researchers are also exploring the potential of other biomarkers to identify and monitor OSA-related damage. Share your thoughts on this research in the comments below, and please share this article with anyone who might find it helpful.
